-
1 Comment
Garofalo Health Care S.p.A is currently in a long term uptrend where the price is trading 11.9% above its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.2.
Finally, its free cash flow fell by 57.0% to $2M since the same quarter in the previous year.
Based on the above factors, Garofalo Health Care S.p.A gets an overall score of 2/5.
ISIN | IT0005345233 |
---|---|
Sector | Healthcare |
Industry | Medical Care Facilities |
Exchange | F |
CurrencyCode | EUR |
Target Price | None |
---|---|
Beta | 0.38 |
Market Cap | 465M |
PE Ratio | 21.33 |
Dividend Yield | None |
Garofalo Health Care S.p.A., together with its subsidiaries, operates healthcare clinics in Italy. It operates through Hospital and Social/Dependency Care segments. The company offers high-complexity surgery, medium- and low-complexity surgery, emergency surgery, medicine, clinical and interventional cardiology, and extended and intensive care units, as well as motor, neurological, cardiac, and nutritional rehabilitation. It also operates centers for patients in coma and persistent vegetative states; and psychiatric and diagnostic centers. Garofalo Health Care S.p.A. was founded in 2000 and is based in Rome, Italy. Garofalo Health Care S.p.A. is a subsidiary of Larama 98 S.p.A.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for GHC.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025